Search

Search Constraints

You searched for: Author/Creator Anstee, Quentin M.

Search Results

1. A Machine Learning Approach Enables Quantitative Measurement of Liver Histology and Disease Monitoring in NASH. Issue 1 (24th June 2021)

2. An international survey on patterns of practice in NAFLD and expectations for therapies—The POP‐NEXT project. Issue 6 (26th April 2022)

3. Case definitions for inclusion and analysis of endpoints in clinical trials for nonalcoholic steatohepatitis through the lens of regulatory science. Issue 5 (22nd February 2018)

4. Cenicriviroc (CVC) for the Treatment of Liver Fibrosis in Adults With Nonalcoholic Steatohepatitis (NASH): AURORA Phase 3 Study Design: 2942. (October 2019)

6. Cirrhosis regression is associated with improved clinical outcomes in patients with nonalcoholic steatohepatitis. Issue 5 (7th February 2022)

7. Comparison of clinical prediction rules for ruling out cirrhosis in nonalcoholic fatty liver disease (NAFLD). Issue 11 (17th March 2022)

8. Current and future therapeutic regimens for nonalcoholic fatty liver disease and nonalcoholic steatohepatitis. Issue 1 (5th July 2018)

9. Diagnostic modalities for nonalcoholic fatty liver disease, nonalcoholic steatohepatitis, and associated fibrosis. Issue 1 (5th July 2018)